Showing results (1721-1730 of 1,872) with videos related to
Sort By:
Pageof 188
CJC Open|March 15, 2024
The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 8: Knowledge Gaps and Status of Existing Research Programs in CanadaMarie-Annick Clavel, Harriette G C Van Spall, Laura E Mantella, et al.Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.Emerging Infectious Diseases|May 23, 2020
Zoonotic Vectorborne Pathogens and Ectoparasites of Dogs and Cats in Eastern and Southeast AsiaVito Colella, Viet L Nguyen, Do Y Tan, et al.Cancers|January 30, 2019
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal CancerCarlo Capalbo, Francesca Belardinilli, Domenico Raimondo, et al.Circulation|September 15, 2017
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo)Peter J Kudenchuk, Brian G Leroux, Mohamud Daya, et al.Communications Medicine|November 15, 2022
Human social conditions predict the risk of exposure to zoonotic parasites in companion animals in East and Southeast AsiaVito Colella, Phrutsamon Wongnak, Yi-Lun Tsai, et al.British Journal of Haematology|May 15, 2024
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registryB Ferment, J Lambert, D Caillot, et al.Blood|April 21, 2024
RAS/RAF landscape in monoclonal plasma cell conditionsAnais Schavgoulidze, Jill Corre, Mehmet Kemal Samur, et al.Critical Care Medicine|December 11, 2019
Relationship Between Duration of Targeted Temperature Management, Ischemic Interval, and Good Functional Outcome From Out-of-Hospital Cardiac ArrestKelly N Sawyer, Andrew Humbert, Brian G Leroux, et al.Plos One|November 19, 2013
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trialStefano Rusconi, Paola Vitiello, Fulvio Adorni, et al.Pageof 188